Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Trends Endocrinol Metab. 2017 Nov 8;28(12):868–878. doi: 10.1016/j.tem.2017.10.007

Table 3.

Recent studies using genetic animal models to investigate the role of MKPs in hepatic metabolism

Gene/Prote in Subcellular Localization Substrate Specificity Genetic manipulation/Other strategies Phenotype in knock-out mouse models Hepatic MKP expression in obesity References
MKP-1 (DUSP1) Nuclear JNK, p38α/β MAPK Leptin receptor-deficient (db/db) mice lacking MKP-1 db/db;mkp-1/ mice exhibit enhanced hepatic β-oxidation and are protected from hepatic steatosis. Undetermined [41]
MKP-1 (DUSP1) Nuclear JNK, p38 α/β MAPK MKP-1 liver- specific knock-out mice MKP-1 liver- specific KO mice exhibit hepatic insulin resistance and are protected from the development of hepatic steatosis by MKP-1 to regulating FGF21. Overexpression of MKP-1 in obesity [25]
MKP-3 (DUSP6) Cytosolic ERK MKP-3 whole-body knock-out mice Resistant to diet-induced obesity, protection from hepatic steatosis, increased energy expenditure, improved systemic insulin sensitivity Undetermined [49]